Comera Life Sciences Holdings, Inc.
CMRA
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 30.00% | 84.46% | 13.83% | -46.37% | -236.74% |
| Total Depreciation and Amortization | -3.36% | 14.81% | 14.11% | -1.65% | 23.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.89% | -95.98% | 551.06% | 129.90% | 720.00% |
| Change in Net Operating Assets | -111.17% | -84.91% | 575.35% | 180.60% | 625.68% |
| Cash from Operations | 19.90% | 62.72% | 33.59% | -15.24% | -155.91% |
| Capital Expenditure | 100.00% | -62.86% | -- | 100.00% | -119.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -62.86% | -- | 100.00% | -119.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 67.78% | -- | -- | -- | -- |
| Issuance of Common Stock | 413.80% | -- | 374.17% | -- | 316.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,107.71% | -101.69% | 610.34% | -- | -93.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 156.91% | -198.76% | 84.37% | 58.65% | -268.79% |